Art

J-GLOBAL ID：200902139299343758   Reference number：02A0936645

Large Scale Cohort Study of the Relationship Between Serum Cholesterol Concentration and Coronary Events With Low-Dose Simvastatin Therapy in Japanese Patients With Hypercholesterolemia and Coronary Heart Disease. Secondary Prevention Cohort Study of the Japan Lipid Intervention Trial (J-LIT).

高コレステロール血症と冠状動脈疾患の日本人患者における低用量シンバスタチン治療による血清コレステロール濃度と冠動脈疾患の間の関係に関する大規模コホート研究 日本脂質介入試験(J-LIT)の二次予防コホート研究

Author (9)： MABUCHI H (Kanazawa Univ. Graduate School of Medicine, Kanazawa, JPN) ,  KITA T (Kyoto Univ. Graduate School of Medicine, Kyoto, JPN) ,  MATSUZAKI M (Yamaguchi Univ. Graduate School of Medicine, Ube, JPN) ,  MATSUZAWA Y (Osaka Univ. Graduate School of Medicine, Suita, JPN) ,  NAKAYA N (Fussa General Hospital, Fussa, JPN) ,  OIKAWA S (Nippon Medical School, Tokyo, JPN) ,  SAITO Y (Chiba Univ. Graduate School of Medicine, Chiba, JPN) ,  SASAKI J (International Univ. Graduate School of Health and Welfare, Fukuoka, JPN) ,  ITAKURA H (Ibaraki Christian Univ., Ibaraki, JPN)
Material： Circulation Journal  (Circ J)
Volume： 66  Issue： 12  Page： 1096-1100  Publication year： Dec. 2002 
JST Material Number： F0908A  ISSN： 1346-9843  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： Japan ,...
Semi thesaurus term： *coronary insufficiency

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=02A0936645&from=J-GLOBAL&jstjournalNo=F0908A") }}

JST classification (3)： Clinical application of drugs acting on lipid metabolism  (GW13050X) ,  Treatment for metabolic diseases,nutritional diseases.  (GD05030F) ,  Drug therapy(=pharmacotherapy)for cardiovascular system diseases  (GJ05020M)

Substance index (2)： Cholesterol ,  Simvastatin

Reference (26)：

• 1. National Cholesterol Education Program. Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994; 89: 1333-1445.
• 2. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham Study. JAMA 1986; 256: 2835-2838.
• 3. Stamler J, Wentworth D, Neaton JD. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986; 256: 2823-2828.
• 4. Keys A, Menotti A, Aravanis C, Blackburn H, Djordevic BS, Buzina R, et al. The Seven Countries Study: 2,289 deaths in 15 years. Prev Med 1984; 2: 141-154.
• 5. Pedersen TR, Wilhelmsen L, Faergeman O, Strandberg TE, Thorgeirsson G, Troedsson L, et al. and Scandinavian Simvastatin Survival Study Group: Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.

Terms in the title (15)： 高コレステロール血症 ,  冠状動脈疾患 ,  日本人 ,  患者 ,  低用量 ,  シンバスタチン ,  治療 ,  血清コレステロール ,  冠動脈疾患 ,  大規模コホート研究 ,  日本脂質介入試験 ,  J-LIT ,  二次予防 ,  コホート ,  研究